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osting by EAbstract The large molecular size of antibodies is considered one major factor preventing them
from becoming more efﬁcient therapeutically. It is well established that all camelids have unique
antibodies circulating in their blood called heavy-chain antibodies (HcAbs). Unlike antibodies from
other species, these HcAbs contain a single variable domain and two constant domains (CH2 and
CH3). HcAbs are a novel type of immunoglobulin-like, antigen binding protein with beneﬁcial
pharmacokinetic properties that are ideally suited to targeting cellular antigens for molecular imag-
ing or therapeutic purposes. Since the antigen-binding site of dromedary HcAb is comprised in one
single domain, it was referred to as nanobody. In the present work, the different IgG subclasses
from immunized camel (Camelus dromedairus) were puriﬁed employing their different afﬁnity for
protein A column (PA) and protein G column (PG). Characterization of IgG subclasses was done
by using 12% SDS–PAGE under reducing conditions. Protein bands were visualized after staining
with Coomassie Brilliant Blue, showing two bands at 50 kDa and 30 kDa in case of IgG1 while
IgG2 and IgG3 produce only one band at 46 kDa and 43 kDa respectively. The induction of apop-
tosis by either conventional or nanobodies was evaluated on two different cell lines, Colon and
Hepatic cancer cell (HCT116 and HepG2), using the comet assay. Induced apoptosis were con-
ﬁrmed by visualizing DNA fragmentation bands on 2% agarose gel, and the gel was photographed
under UV light. This study demonstrates the successful targeting of human cancer colon cell lines by. Box 22452, Riyadh 11495,
.
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222 G.H. Shaker, N.A. Melakenanobodies in vitro. It may open perspectives for their future use as tumor target vehicle, due to
their small size, soluble behavior and they interact with epitopes that are less antigenic for conven-
tional antibodies.
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Antibodies are composed of two identical heavy-chains and
two identical light-chains. The IgG from species of camelidae
(Camelus and llama) forms a surprising exception to this par-
adigm as their serum contains also a considerable fraction of
heavy-chain antibodies (HcAbs) that lack the L-chain. These
HcAbs constitute approximately 50% of IgG in llama serum
and as much as 75% of IgG in camel serum (Hamers-Cas-
terman et al., 1993). A nanobody is smaller than a single-chain
Fv fragment, because it lacks both the light chain and the lin-
ker, whereas it has a similar afﬁnity as variable regions of con-
ventional antibodies (Pragnesh et al., 2010).
During the last decade, the U.S. Food and Drug Adminis-
tration have approved 21 mAbs for therapy, mostly for the
systemic treatment of cancer. These mAbs are used to com-
pletely neutralize/block growth factors or growth factor recep-
tors, the key drivers of tumor growth and survival for a
prolonged period (Khalissa et al., 2009).
Several characteristics make nanobody use superior to the
conventional antibodies. They are non-immunogenic and show
high thermal and chemical stability (Cortez-Retamozo et al.,
2002). In addition, it does not show aggregations problems like
single chain Fv because of hydrophilic instead of hydrophobic
patches in the VH and VL domains. Nanobodies show a high
solubility and a good capacity to refold after denaturation
while retaining their binding capacity. There are several re-
ports of raising speciﬁc nanobodies against enzymes, haptens,
pathogens, toxins and tumor markers. All these characteristics
make them strong candidates as targeting agents for cancer
therapy (Khalissa et al., 2009).
Colorectal cancers (CRC) are referred to colon and rectal
cancers together. It causes 655,000 deaths worldwide annually.
The incidence is slightly higher in men than women. The inci-
dence of colorectal cancer is highest in developed countries
such as the United States and Japan and lowest in developing
countries such as Africa and Asia (Wakai et al., 2006). CRC
represents 8.5% of all tumors in Saudi Arabia as reported
from studies published in the literature in the past 30 years
(Abdulrahman, 2007).
Hepatocellular carcinoma (HCC) is a primary malignancy
of the liver. Most cases of HCC are secondary to either a viral
hepatitis infection (hepatitis B or C) or cirrhosis (Kumar et al.,
2003). HCC, like any other cancer, develops when there is a
mutation to the cellular machinery that causes the cell to rep-
licate at a higher rate and/or results in the cell avoiding apop-
tosis (Chien et al., 2006).
Many antitumor agents, have been reported to induce an
apoptotic type of death in susceptible cells, thus apoptosis in
tumor cells plays a critical role in killing tumor cells during
cancer therapy (Zahri et al., 2009).
Commonly used techniques for the estimation of apoptosis
are comet assay and DNA fragmentation assay (Narendra,
2000). The comet is a rapid and sensitive method for thedetection of DNA damage in individual cells, induced by a
variety of genotoxic agents. It was ﬁrst introduced by O¨stling
and Johanson (1984), and later modiﬁed independently by
Singh et al. (1988) and Olive (1989). Image analysis provides
three important parameters for each comet: tail length, tail
ﬂuorescence intensity and tail moment (Collins et al., 1997).
There has been increasing interest in the comet assay as the
method used in various in vitro as well as in vivo studies to eval-
uate DNA damage and repair.
In this study, the aim was to compare the apoptotic effect of
nanobodies (IgG2 and IgG3) and conventional antibodies
(IgG1) on two different cancer cell lines (Human colon cancer
and Human hepatic carcinoma). The camel IgGs were frac-
tionated into its various subclasses by afﬁnity chromatography
and the apoptotic effects were estimated by using comet assay
and DNA fragmentation methods.
2. Materials and methods
2.1. Dromedary immunization
An adult male dromedary (Camelus dromedarius) reared in the
Camel Breeding Farm of the Ministry of Agriculture (Saudi
Kingdom) was immunized for induction of antibodies and
nanobodies. A camel was injected subcutaneously with 100,
75, 75, 50 and 50 lg EGFRvIII-ECD on days 1, 21, 36, 50
and 64, respectively according to Ghahroudi et al. (1997).
Complete Freund’s adjuvant was used for the primary immu-
nization (Sigma, St. Louis, MO), incomplete Freund’s adju-
vant for immunization 2–4 (Sigma, St. Louis, MO), and no
adjuvant for the ﬁnal immunization. The camel was bled one
week following each immunization and the blood was collected
aseptically in sterile containers containing heparin as anticoag-
ulant, and then stored at –80 C until further use. Procedures
for production and puriﬁcation of extracellular domains of
EGFR were performed in The Animal Reproduction Research
Institute, Egypt according to Brown et al. (1994). The protocol
of this study was carried out according to the regulations and
recommendation of the Animal Research Ethics Committee of
College of Pharmacy, KSU, SA.
2.2. Separation of the IgG subclasses
IgG subclass was fractionated by a combination of afﬁnity
chromatography on PG and PA columns. Final protein con-
centration of the isolated serum fractions was determined by
the Bradford method (Bio-Rad. Hercules, CA, and USA)
and protein purity was assayed by 12% sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis (SDS–PAGE) under
reducing condition as described previously by Shaker (2010).
2.3. Cell culture and treatments
The cell lines HCT116 and HepG2 were obtained from the
Department of Life Science and Biotechnology, Faculty of
Figure 1 Changes of tail length (lm) induced with different
concentrations of IgG subclasses on HCT116 cell lines.
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Japan. The cell lines were grown in the culture medium
consisted of Weymouth MB 752 medium (Gibco) containing
10–15% fetal calf serum and supplemented with 300 lg/ml
ascorbic acid (Sigma), 30 lg/ml hydrocortisone-21-sodium
succinate (Sigma), 45 lg/ml ferrous sulfate, 100 units/ml peni-
cillin/streptomycin solution (Gibco) and 100 units/ml mycost-
atin suspension (Gibco). The pH of the medium was checked
and adjusted to 7.4 before ﬁlter sterilization (Millipore Millex).
The gas phase consisted of 95% oxygen and 5% carbon
dioxide for 48 h (Hodges and Melicher, 1976).
2.4. Comet assay (SCGE)
The comet assay was performed in concordance with the
premises established by Singh et al. (1988) with some modiﬁca-
tions. Brieﬂy, after 24 h of exposure of HCT116 and HepG2
cells to the tested substance in different Petri-dishes
(60 · 15 mm, Greiner), the cells were trypsinized (0.1% for
4 min), suspended, homogenized in 1 ml of medium and centri-
fuged (10 min at 800 rpm). Subsequently 600 ll of Low Melt-
ing Agarose (0.8% in PBS) was added to the cell suspension
(100 ll). Then 100 ll of this mixture was transferred to agarose
pre-coated slides. The coated slides were immersed in lyses buf-
fer (0.045 M TBE, pH 8.4, containing 2.5% SDS) for 15 min.
The slides were placed in electrophoresis chamber containing
the same TBE buffer, but devoid of SDS. The electrophoresis
conditions were 2 V/cm for 2 min and 100 mA. Staining was
done by ethidium bromide (20 lg/ml at 4 C, Sigma). The
observation was with the samples still humid, the DNA frag-
ment migration patterns of 100 cells for each dose level were
evaluated with a ﬂuorescence microscope (with excitation ﬁlter
420–490 nm [issue 510 nm]). The comets tails lengths were
measured from the middle of the nucleus to the end of the tail
with 40x increase for the count and measure the size of the
comet. For visualization of DNA damage, observations are
made of ethidium bromide-stained DNA using a 40x objective
on a ﬂuorescent microscope using public domain software for
image analysis based on comet 5 image analysis software
developed by Kinetic Imaging, Ltd. (Liverpool, UK) linked
to a CCD camera. DNA damage was measured as tail length
(TL = distance of DNA migration from the center of the body
of the nuclear core), and tail intensity DNA (TI =% of geno-
mic DNA that migrated during the electrophoresis from the
nuclear core to the tail). By presenting all 3 parameters
together, more information on the extent of the DNA damage
can be obtained.
2.5. DNA fragmentation (Ladder) assay
In DNA laddering assay, low molecular weight fragments of
oligo-nucleosomal DNA are extracted selectively from the cells
whereas the higher molecular weight DNA stays associated
with the nuclei. The isolated DNA is separated by electropho-
resis and visualized using ethidium bromide. Brieﬂy, 5x106 cells
were resuspended in 500 ll Tris–EDTA buffer and lysed with
0.2% Triton X-100. DNA was precipitated in ethanol for 6 h
in the presence of 0.5 M NaCl. The high molecular weight frac-
tion was sediment by high-speed centrifugation, and the frag-
mented DNA was extracted from the aqueous phase with
phenol and chloroform and then precipitated with isopropa-
nol. After resuspension in Tris–EDTA buffer, the sampleswere incubated with RNase A (0.1 mg/ml) for 30 min at
37 C. Finally, DNA was electrophoresed using 2% agarose
gel and visualized by ultraviolet light following ethidium bro-
mide staining (Mariarosaria et al., 2003).
2.6. Statistical analyses
Computer SPSS program version 17 was used. The results
were expressed by applying Chi-square test and P values. P va-
lue < 0.05 was considered to be signiﬁcant.
3. Results
3.1. Separation and characterization of camel IgG fractions
The IgG was successfully fractionated into its various subclass-
es by using PG and PA afﬁnity chromatography as described
by Shaker (2010). PG afﬁnity chromatography allowed the iso-
lation of one HcAb subclass (fraction, camel IgG3) and the
conventional antibody subclass IgG1 fraction. PA chromatog-
raphy results revealed the presence of another HcAb subclass
fraction corresponding to camel IgG2. The eluted fractions
from PA and PG chromatography were analyzed by 12%
SDS–PAGE with reducing agent. Protein bands were visual-
ized after staining with 0.1% Coomassie Blue R250. Fraction
IgG1, upon reduction, yielded two bands, 50 kDa heavy chains
and 30 kDa light chains. The two other immunoglobulin frac-
tions, upon reduction, yielded only heavy chains of 46 kDa
(IgG2 fraction binding only to PA) and 43 kDa (IgG3 fraction
binding to PG). These IgG2 and IgG3 subclasses appeared to
lack the light chain completely.
3.2. The Comet DNA assay (SCGE)
Figs. 1–4 summarize the results of the comet assay of the three
puriﬁed IgG subclasses at different concentrations (0.1, 0.01
and 0.001ug/ml) on the cell lines HCT116 and HepG2. It could
be easily noticed in Fig. 1, that tail length as marker for DNA
fragmentation was increased at all concentrations tested by
IgG subclasses on HCT116 cell lines and it was clearly obvious
and potent with IgG2 and IgG3 fractions (nanobodies) than
IgG1 (conventional antibody), while all IgG subclasses have
Figure 2 Changes of tail length (lm) induced with different
concentrations of IgG subclasses on HepG2 cell lines.
Figure 4 Photographic pictures of DNA fragment migration patterns
(with excitation ﬁlter 420–490 nm). (A) Intact cells (control); most of
0.1 lg/ml of puriﬁed IgG fractions; the presence of the tail reﬂect the
Figure 3 Comparison between comet assay results (Tail
moment) obtained due to the effects of IgG subclasses on the
tested cell lines (HCT116 and HepG2).
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tained with the tail moment which shows same pattern of
changes (Fig. 3). Visualization of the DNA damage by using
a 40· objective lens on a ﬂuorescent microscope has been
shown in Fig. 4, using public domain software (Fig. 4B shows
DNA damage and increased tail length while Fig. 4A shows
control intact cells).
3.3. DNA fragmentation assay (DNA laddering assay)
Fig. 5a, b and c reveals the results of DNA fragmentation
assay. Formation of fragmented DNA, one of the typical
apoptotic characters, was detected by the DNA ladder assay.
It was observed by treating both cell lines (HepG2 and
HCT116) with IgG subclasses (Fig. 5a). A DNA laddering,
due to multiple DNA fragments, was detected only in the
supernatant fraction of HCT116 cell lines treated with IgG
subclasses fractions, IgG1 (lanes 10 and 11), IgG2 (lanes 12
and 13) and IgG3 (lanes 14 and 15). The DNA fragmentation
is very typical of apoptotic process with generation within the
nucleus of a series of multiples of a 180–200 bp subunit. Figs.
5b and 5c detect DNA fragmentation assay results versus the
number of fragmented bands and percentage of compact
DNA in the nucleus respectively.
4. Discussion
Despite signiﬁcant advances in understanding the molecular
aspects of cancer, conventional therapies have not changed
dramatically within the past 25 years. The toxicities and ad-
verse side effects of these therapies and the frequent emergence
of resistance in recurrent tumors have led to a considerable in-
crease in the clinical testing of monoclonal antibodies as single-
agent anticancer therapies or as facilitators of tumor cell death
in combination with existing therapies or search for alternative
delivery of nonconventional therapy. Antibodies realizing their
potential as anticancer therapeutics are still amenable for
improvement in terms of functionality (e.g., stability, afﬁnity,
speciﬁcity and size) and pharmacokinetic properties (Carter,
2001). Reducing the size of the conventional antibody to a
Fab or scFv by cloning the corresponding gene fragments
and expression in bacteria is becoming a standard techniqueby alkaline comet assay evaluated with a ﬂuorescence microscope
DNA is located in the head of the comet. (B) Cell lines treated by
DNA damage.
Figure 5a Detection of the effects of IgG subclasses on the tested
cell lines by 2% agarose gel electrophoresis. Lanes: 1, 2 and 3: the
buffers used for separation of IgG1, IgG2 and IgG3 respectively;
lanes 4 and 5: effect of IgG1 on HepG2; lanes 6 and 7: effect of
IgG2 on HepG2; lanes 8 and 9: effect of IgG3 on HepG2; while,
lanes 10 and 11: effect of IgG1 on HCT116; lanes 12 and 13: effect
of IgG2 on HCT116; lanes 14 and 15: effect of IgG3 on HCT116.
Lane M: DNA molecular weight marker.
Figure 5b DNA fragmentation assay results for studied cell lines
(HepG2 and HCT116) after treatment by IgG subclasses vs. the
number of fragmented bands.
Figure 5c Compact DNA% assay results for studied cell lines
after treatment by IgG subclasses.
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antibodies in camelids creates a new opportunity to obtain
soluble antigen-binding fragments of minimal size. These
antibodies can be afﬁnity-matured in vivo to yield molecules
that interact via one variable domain with the antigen with
adequate afﬁnity and speciﬁcity. This variable fragment of
15 kDa with a typical immunoglobulin fold is called a nano-
body (Vu et al., 1997).
Poor tissue penetration is a serious obstacle to the success-
ful development of antibody therapeutics in particular for
immunotherapy of solid tumors (Beckman et al., 2007). Anti-
bodies and other anticancer agents have to overcome severalbarriers to reach their binding sites on the tumor cell. These
barriers include systemic clearance, transport across the
vasculature, limited convective ﬂow and high interstitial pres-
sure gradients. The rate of diffusion is a function of size and
is approximately inversely proportional to molecular weight
so a monovalent nanobody would be expected to saturate a tu-
mor 10 times faster than a full-length IgG (Joost and Debbie,
2010). The easy generation and manufacturing yield of nano-
body-based conjugates together with their potent antitumor
activity make nanobodies promising vehicles for new genera-
tion cancer therapeutics (Virna et al., 2004).
The purpose of this study was to evaluate apoptotic effect
of nanobodies as antitumor activity against HCT116 and
HepG2 cell lines. We described the isolation of IgG subclasses
(IgG1, IgG2 and IgG3) from the immunized camel serum
using combination of afﬁnity chromatography on PG and
PA columns. The successful separation of the target nanobod-
ies was ascertained by SDS–PAGE electrophoresis and was
supported by the work of Daley et al. (2005), who used the
same columns to purify llama IgG isotype. Comet assay and
nuclear staining were used for the assessment of apoptotic
effect of puriﬁed IgG subclasses.
Several investigators have concluded that based on the
characteristic appearance of the comets, apoptotic cells can
be readily distinguished from necrotic cells in the alkaline
SCG assay (Olive et al., 1993). Apoptotic cells were concluded
to form comets with large fan-like tails and small heads (called
hedgehogs), while necrotic cells were concluded to form comets
with relatively large heads and narrow tails of varying lengths
(i.e., comets indistinguishable from those resulting from geno-
toxic damage).
The alkaline comets have a broader and more fragmented
appearance and the tails are distinctly separated from the
head. Practically the entire tail moves in the direction of a
changed electric ﬁeld. The single strands in partially double
stranded DNA will easily entangle with other DNA molecules
in the lysed nucleus, which will inhibit their possibility to es-
cape from the head of the comet into the gel. The forked struc-
ture at the ends and the fact that partially single stranded
fragments are bigger in size than the single stranded ones
may inhibit the speed in the gel.
We have thus two types of molecules with widely different
travelling speeds. The tail and head are therefore clearly sepa-
226 G.H. Shaker, N.A. Melakerated by a waist in alkaline gels, in contrast to the continuous
head and tail in neutral gels. As shown by the pictures the
clearly obvious changes of tail length were demonstrated with
different concentrations of IgG subclasses on HCT116 cell
lines. It was clear that the tail length as marker for DNA frag-
mentation was increased at all concentrations used by IgG
subclasses but it was potent with IgG2 and IgG3 fractions
(nanobodies) than IgG1(conventional antibody). While all
IgG subclasses have no effect on HepG2 cell line as compared
with control culture. The best way to quantify the amount of
DNA damage using digital comet image is by combining tail
length and distribution of DNA in the tail (tail moment). Val-
ues for calculated tail moments for apoptotic cells are extre-
mely high due to the large fraction of DNA in the tail and
the pronounced distance of migration during electrophoresis.
A certain fraction of cells is undamaged and thus retain low
tail moments. A tail moment of greater than about 110 is indic-
ative of apoptosis (Benjamin et al., 1997). This was achieved in
our study with IgG2 and IgG3 fractions (nanobodies). To con-
ﬁrm the apoptotic effect of the comet results, we further exam-
ined the apoptotic response, as judged by the appearance of a
DNA ladder through agarose gel electrophoresis. DNA Lad-
dering is a characteristic pattern of DNA fragmentation, which
is the hallmark of apoptosis. DNA fragmentation is one of the
later stages of apoptosis (Saraste and Pulkki, 2000). Visual
inspection of our images supports the ﬁndings of the comet as-
say which revealed that, IgG subclasses induced massive apop-
tosis only in the case of cancer colon. These ﬁnding may be
explained by high expression of tumor antigens such as carci-
noembryonic antigen (CEA) on cancer cells of epithelial origin
(colorectal carcinoma) (Pragnesh et al., 2010), where they are
not expressed in other cells of the body except for low-level
expression in gastrointestinal tissue. This is in agreement with
the study of Cortez-Retamozo et al. (2004), who revealed that,
in oncology, HcAbs directed against CEA was used for target-
ing the genetically fused b-lactamase to tumor cells. This en-
zyme then converts an injected nontoxic prodrug into a toxic
drug in the vicinity of the targeted tumor cells, leading to their
killing.5. Conclusion
We propose that nanobodies warrant further investigation as
alternatives to conventional antibodies for therapeutic applica-
tions because of (1) their potentially better tumor penetration;
(2) their potentially higher production yield due to a simpler
two-chain molecular structure; (3) their lower dose require-
ments due to lower molecular weight and (4) versatility
(Andrea et al., 2010). Many of these inherent biophysical char-
acteristics of nanobodies distinguish them from conventional
antibodies and imbue them with several properties which make
them well suited for drug development.
Massive fragmentation of cellular DNA makes apoptotic
cells easy to distinguish using the comet assay, as almost the
entire volume of DNA migrates outside the head of the comet.
Comet test has many advantages, cell/cell approach, applicable
on many cell types, no in vitro cultivation step required, cheap,
fast, simplicity, and give indication on apoptosis. Overall our
results demonstrated in the present in vitro study that nano-
bodies effectively induce more apoptosis on cancer colon than
conventional antibodies, while both types have no apoptoticeffect on hepatocellular carcinoma. Nanobodies might soon
have reached a level of maturity that positions it as a highly
robust and effective next generation biologics platform.Acknowledgment
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